Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem/progenitor cells

Xiaohua Wu, Selina A. Estwick, Shi Chen, Menggang Yu, Wenyu Ming, Todd Nebesio, Yan Li, Jin Yuan, Reuben Kapur, David Ingram, Mervin Yoder, Feng Chun Yang

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Mutations in the NF1 tumor suppressor gene cause neurofibromatosis type 1, a pandemic autosomal dominant genetic disorder with an incidence of 1:3000. Individuals with NF1 have a variety of malignant and non-malignant manifestations, including skeletal manifestations, such as osteoporosis, scoliosis and short statures. However, the mechanism(s) underlying the osseous manifestations in NF1 are poorly understood. In the present study, utilizing Nf1 haploinsufficient (+/-) mice, we demonstrate that Nf1 +/- mesenchymal stem/progenitor cells (MSPC) have increased proliferation and colony forming unit-fibroblast (CFU-F) capacity compared with wild-type (WT) MSPC. Nf1 +/- MSPC also have fewer senescent cells and have a significantly higher telomerase activity compared with WT MSPC. Nf1 +/- MSPC have impaired osteoblast differentiation as determined by alkaline phosphatase staining, and confirmed by single CFU-F replating assays. The impaired osteoblast differentiation in Nf1 +/- MSPC is consistent with the reduced expression of osteoblast markers at the mRNA level, including osteocalcin and osteonectin. Importantly, re-expression of the full-length NF1 GTPase activating related domain (NF1 GAP-related domain) is sufficient to restore the impaired osteoblast differentiation in Nf1 +/- MSPC. Taken together, our results suggest that neurofibromin plays a crucial role in modulating MSPC differentiation into osteoblasts, and the defect in osteoblast differentiation may contribute at least in part to the osseous abnormalities seen in individuals with NF1.

Original languageEnglish
Pages (from-to)2837-2845
Number of pages9
JournalHuman Molecular Genetics
Volume15
Issue number19
DOIs
StatePublished - Oct 1 2006

Fingerprint

Neurofibromin 1
Osteoblasts
Mesenchymal Stromal Cells
Stem Cells
Fibroblasts
Osteonectin
Inborn Genetic Diseases

ASJC Scopus subject areas

  • Genetics

Cite this

Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem/progenitor cells. / Wu, Xiaohua; Estwick, Selina A.; Chen, Shi; Yu, Menggang; Ming, Wenyu; Nebesio, Todd; Li, Yan; Yuan, Jin; Kapur, Reuben; Ingram, David; Yoder, Mervin; Yang, Feng Chun.

In: Human Molecular Genetics, Vol. 15, No. 19, 01.10.2006, p. 2837-2845.

Research output: Contribution to journalArticle

Wu, Xiaohua ; Estwick, Selina A. ; Chen, Shi ; Yu, Menggang ; Ming, Wenyu ; Nebesio, Todd ; Li, Yan ; Yuan, Jin ; Kapur, Reuben ; Ingram, David ; Yoder, Mervin ; Yang, Feng Chun. / Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem/progenitor cells. In: Human Molecular Genetics. 2006 ; Vol. 15, No. 19. pp. 2837-2845.
@article{7800286a089b4b0088240bd985073127,
title = "Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem/progenitor cells",
abstract = "Mutations in the NF1 tumor suppressor gene cause neurofibromatosis type 1, a pandemic autosomal dominant genetic disorder with an incidence of 1:3000. Individuals with NF1 have a variety of malignant and non-malignant manifestations, including skeletal manifestations, such as osteoporosis, scoliosis and short statures. However, the mechanism(s) underlying the osseous manifestations in NF1 are poorly understood. In the present study, utilizing Nf1 haploinsufficient (+/-) mice, we demonstrate that Nf1 +/- mesenchymal stem/progenitor cells (MSPC) have increased proliferation and colony forming unit-fibroblast (CFU-F) capacity compared with wild-type (WT) MSPC. Nf1 +/- MSPC also have fewer senescent cells and have a significantly higher telomerase activity compared with WT MSPC. Nf1 +/- MSPC have impaired osteoblast differentiation as determined by alkaline phosphatase staining, and confirmed by single CFU-F replating assays. The impaired osteoblast differentiation in Nf1 +/- MSPC is consistent with the reduced expression of osteoblast markers at the mRNA level, including osteocalcin and osteonectin. Importantly, re-expression of the full-length NF1 GTPase activating related domain (NF1 GAP-related domain) is sufficient to restore the impaired osteoblast differentiation in Nf1 +/- MSPC. Taken together, our results suggest that neurofibromin plays a crucial role in modulating MSPC differentiation into osteoblasts, and the defect in osteoblast differentiation may contribute at least in part to the osseous abnormalities seen in individuals with NF1.",
author = "Xiaohua Wu and Estwick, {Selina A.} and Shi Chen and Menggang Yu and Wenyu Ming and Todd Nebesio and Yan Li and Jin Yuan and Reuben Kapur and David Ingram and Mervin Yoder and Yang, {Feng Chun}",
year = "2006",
month = "10",
day = "1",
doi = "10.1093/hmg/ddl208",
language = "English",
volume = "15",
pages = "2837--2845",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "19",

}

TY - JOUR

T1 - Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem/progenitor cells

AU - Wu, Xiaohua

AU - Estwick, Selina A.

AU - Chen, Shi

AU - Yu, Menggang

AU - Ming, Wenyu

AU - Nebesio, Todd

AU - Li, Yan

AU - Yuan, Jin

AU - Kapur, Reuben

AU - Ingram, David

AU - Yoder, Mervin

AU - Yang, Feng Chun

PY - 2006/10/1

Y1 - 2006/10/1

N2 - Mutations in the NF1 tumor suppressor gene cause neurofibromatosis type 1, a pandemic autosomal dominant genetic disorder with an incidence of 1:3000. Individuals with NF1 have a variety of malignant and non-malignant manifestations, including skeletal manifestations, such as osteoporosis, scoliosis and short statures. However, the mechanism(s) underlying the osseous manifestations in NF1 are poorly understood. In the present study, utilizing Nf1 haploinsufficient (+/-) mice, we demonstrate that Nf1 +/- mesenchymal stem/progenitor cells (MSPC) have increased proliferation and colony forming unit-fibroblast (CFU-F) capacity compared with wild-type (WT) MSPC. Nf1 +/- MSPC also have fewer senescent cells and have a significantly higher telomerase activity compared with WT MSPC. Nf1 +/- MSPC have impaired osteoblast differentiation as determined by alkaline phosphatase staining, and confirmed by single CFU-F replating assays. The impaired osteoblast differentiation in Nf1 +/- MSPC is consistent with the reduced expression of osteoblast markers at the mRNA level, including osteocalcin and osteonectin. Importantly, re-expression of the full-length NF1 GTPase activating related domain (NF1 GAP-related domain) is sufficient to restore the impaired osteoblast differentiation in Nf1 +/- MSPC. Taken together, our results suggest that neurofibromin plays a crucial role in modulating MSPC differentiation into osteoblasts, and the defect in osteoblast differentiation may contribute at least in part to the osseous abnormalities seen in individuals with NF1.

AB - Mutations in the NF1 tumor suppressor gene cause neurofibromatosis type 1, a pandemic autosomal dominant genetic disorder with an incidence of 1:3000. Individuals with NF1 have a variety of malignant and non-malignant manifestations, including skeletal manifestations, such as osteoporosis, scoliosis and short statures. However, the mechanism(s) underlying the osseous manifestations in NF1 are poorly understood. In the present study, utilizing Nf1 haploinsufficient (+/-) mice, we demonstrate that Nf1 +/- mesenchymal stem/progenitor cells (MSPC) have increased proliferation and colony forming unit-fibroblast (CFU-F) capacity compared with wild-type (WT) MSPC. Nf1 +/- MSPC also have fewer senescent cells and have a significantly higher telomerase activity compared with WT MSPC. Nf1 +/- MSPC have impaired osteoblast differentiation as determined by alkaline phosphatase staining, and confirmed by single CFU-F replating assays. The impaired osteoblast differentiation in Nf1 +/- MSPC is consistent with the reduced expression of osteoblast markers at the mRNA level, including osteocalcin and osteonectin. Importantly, re-expression of the full-length NF1 GTPase activating related domain (NF1 GAP-related domain) is sufficient to restore the impaired osteoblast differentiation in Nf1 +/- MSPC. Taken together, our results suggest that neurofibromin plays a crucial role in modulating MSPC differentiation into osteoblasts, and the defect in osteoblast differentiation may contribute at least in part to the osseous abnormalities seen in individuals with NF1.

UR - http://www.scopus.com/inward/record.url?scp=33749024989&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749024989&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddl208

DO - 10.1093/hmg/ddl208

M3 - Article

C2 - 16893911

AN - SCOPUS:33749024989

VL - 15

SP - 2837

EP - 2845

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 19

ER -